Skip to search
Skip to main content
Back to Search
Start Over
CARTITUDE-2: Efficacy and safety of ciltacabtagene autoleucel (cilta-cel), a BCMA-directed CAR T-cell therapy, in patients with progressive multiple myeloma (MM) after one to three prior lines of therapy.
Authors :
Agha, Mounzer E. Cohen, Adam D. Madduri, Deepu Cohen, Yael C. Delforge, Michel Hillengass, Jens Goldschmidt, Hartmut Weisel, Katja Raab, Marc-Steffen Scheid, Christof Schecter, Jordan Mark De Braganca, Kevin C. Varsos, Helen Wang, Liwei Vogel, Martin Carrasco-Alfonso, Marlene Akram, Muhammad Wu, Xiaoling Nesheiwat, Tonia Einsele, Hermann Agha, Mounzer E. Cohen, Adam D. Madduri, Deepu Cohen, Yael C. Delforge, Michel Hillengass, Jens Goldschmidt, Hartmut Weisel, Katja Raab, Marc-Steffen Scheid, Christof Schecter, Jordan Mark De Braganca, Kevin C. Varsos, Helen Wang, Liwei Vogel, Martin Carrasco-Alfonso, Marlene Akram, Muhammad Wu, Xiaoling Nesheiwat, Tonia Einsele, Hermann
Publication Year :
2021
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1312207925
Document Type :
Electronic Resource